tumor necrosis factor inhibitors
Adalimumab is used in the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis and crohn's disease Adalimumab blocks the action of certain chemical messengers that are responsible for inflammation, swelling and redness associated with certain joint diseases